Company Filing History:

6 out of 145

Merck Serono S. A.

Geneva University Hospitals

patents

5. 1 out of 40

Laboratoires Serono S.a.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252472 - Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer (2025-03-18),

2. 12240820 - Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer (2025-03-04),

3. 11492333 - Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer (2022-11-08),

4. 8143056 - Vascular adhesion molecules and modulation of their function (2012-03-27),

5. 8093010 - Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer (2012-01-10),

6. 8007797 - Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use (2011-08-30),

7. 7790863 - Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer (2010-09-07),

8. 7670826 - Confluence regulated adhesion molecules useful in modulating vascular permeability (2010-03-02),

9. 7642341 - Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer (2010-01-05),

10. 7393651 - Confluence regulated adhesion molecules useful in modulating vascular permeability (2008-07-01),

11. 7033794 - Basolateral sorting signal and inhibitors thereof (2006-04-25),

Title: Beat Albert Imhof: Innovator in Barbituric Acid Derivatives

Introduction

Beat Albert Imhof is a prominent inventor based in Conches, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his work on barbituric acid derivatives. With a total of 11 patents to his name, Imhof's innovations are paving the way for new treatments in various medical conditions.

Latest Patents

Imhof's latest patents focus on barbituric acid derivatives, which are designed to act as leukocyte transmigration inhibitors. These compounds are particularly useful in treating inflammatory diseases, autoimmune disorders, and certain types of cancer. The synthesis and application of these novel derivatives aim to block leukocyte transmigration, thereby addressing disorders associated with this process.

Career Highlights

Throughout his career, Beat Albert Imhof has worked with notable organizations, including Merck Serono S.A. and Bar-Ilan University. His experience in these institutions has allowed him to develop and refine his innovative approaches to medicinal chemistry.

Collaborations

Imhof has collaborated with esteemed colleagues such as Michel Aurrand-Lions and Arie Lev Gruzman. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Beat Albert Imhof is a distinguished inventor whose work on barbituric acid derivatives holds promise for the treatment of various medical conditions. His contributions to medicinal chemistry continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com